Rexahn Pharma (RNN) Tops Q1 EPS by 1c

Rexahn Pharma (NYSE: RNN) reported Q1 EPS of ($0.02), $0.01 better than the analyst estimate of ($0.03).

For earnings history and earnings-related data on Rexahn Pharma (RNN) click here.

You May Also Be Interested In

• Nomura/Instinet Upgrades Genting Singapore (GENS:SP) (GIGNY) to Neutral
• Calidi Biotherapeutics (CLDI) Reports Q2 Loss of $2.94
• Agora Inc. (API) PT Raised to $6.80 at BofA Securities